Nexvet Biopharma (NVET) Flat on Study Results

Nexvet Biopharma plc (NASDAQ: NVET) shares rose 0.1% to $2.93 as the company reported positive results from NV-02 pilot field study in cats with osteoarthritis. Share volume was 102,000 compared to an all-day average of 11,000